Human 15q13.3 Deletion [Df(h15q13)/+] Mouse

Constitutive Knockout (Genomic Deletion)

Human 15q13.3 deletion [Df(h15q13)/+] mouse
Live production of model 10962 will cease by Nov 21, 2018 in the US and by Dec 21, 2018 in Europe. Please contact Taconic to discuss your future needs for this model.

C57BL/6 Background

  • Model #
  • Genotype
  • Nomenclature
  • 10962-F
  • 10962-M
  • 10962-F
  • 10962-M
  • Carries a genomic deletion of a region of mouse chromosome 7 that corresponds to human chromosome region 15q13.3.
  • In humans, hemizygous deletion of chromosome 15q13.3 confers high risk of schizophrenia, autism, and epilepsy in human patients
  • Schizophrenia related phenotype: EEG characterization revealed auditory processing deficits similar to those observed in schizophrenia. They have impaired long-term spatial reference memory and decreased performance in the novel object recognition task.
  • Epilepsy related phenotype: Human 15q13.3 deletion mice show changes in neuronal excitability in acute seizure assays, with increased propensity to develop myoclonic and absence-line seizures; decreased propentisty for clonic and tonic seizures.
  • Useful as a model of schizophrenia-like pathology and studying the underlying biology of schizophrenia, epilepsy, and other neural circuit defects associated with 15q13.3 deletion in humans
Orders by weight: Taconic cannot accept orders by weight for this model. Please note that shipments may contain animals with a larger weight variation.


The Df(h15q13)/+ mouse line was developed for H. Lundbeck A/S at Taconic Biosciences GmbH (Cologne, Germany). Two targeting vectors were generated using bacterial artificial chromosome clones from the C57BL/6J RPCI-23 library and transfected into TaconicArtemis C57BL/6N Tac embryonic stem cell line. The first vector introduced a loxP site upstream of the Chrna7 gene. The second vector introduced a loxP site downstream of the Fan1 gene. Homologous recombinant clones were isolated and the 1.28 megabase region on mouse chromosome 7 between the loxP sites was removed using in vitro Cre-mediated recombination. Hemizygotic embryonic stem cells were injected into blastocysts isolated from impregnated BALB/c female mice and transferred to pseudopregnant NMRI female mice. Chimeric male pups were selected by coat color and mated with wild-type C57BL/6 female mice. Finally, a chimera with germline transmission was selected for expansion breeding. The colony is maintained by mating wild-type C57BL/6N mice with hemizygous Df(h15q13)/+ mice.


Available off-the shelf





Initial Publication:

Fejgin K, Nielsen J, Birknow MR, Bastlund JF, Nielsen V, Lauridsen JB, Stefansson H, Steinberg S, Sorensen HB, Mortensen TE, Larsen PH, Klewe IV, Rasmussen SV, Stefansson K, Werge TM, Kallunki P, Christensen KV, Didriksen M. (2014) A mouse model that recapitulates cardinal features of the 15q13.3 microdeletion syndrome including schizophrenia- and epilepsy-related alterations. Biol Psychiatry. 2014 Jul 15;76(2):128-37.

Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions of Sale and the following terms of use:

  • Title to these Models and biological materials derived from them remains with Taconic Biosciences, Inc.
  • The Models will be used for research purposes only.
  • The Models will not be bred except to obtain embryos or fetuses required for research purposes
  • The Models and biological materials derived from them will not be distributed to third parties or used for commercial purposes.